These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9772368)

  • 61. VEGF modulates NO production: the basis of a cytoprotective effect?
    Servos S; Zachary I; Martin JF
    Cardiovasc Res; 1999 Mar; 41(3):509-10. PubMed ID: 10435021
    [No Abstract]   [Full Text] [Related]  

  • 62. Developing strategies for therapeutic angiogenesis: vascular endothelial growth factor alone may not be the answer.
    Clover AJ; McCarthy MJ
    Br J Plast Surg; 2003 Apr; 56(3):314. PubMed ID: 12859941
    [No Abstract]   [Full Text] [Related]  

  • 63. Dilemma of angiogenesis.
    SoRelle R
    Circulation; 2000 Jan; 101(2):E23-4. PubMed ID: 10637212
    [No Abstract]   [Full Text] [Related]  

  • 64. Vascular endothelial growth factor--its role in retinal vascular proliferation.
    Frank RN
    N Engl J Med; 1994 Dec; 331(22):1519-20. PubMed ID: 7526213
    [No Abstract]   [Full Text] [Related]  

  • 65. Developing strategies for therapeutic angiogenesis: vascular endothelial growth factor alone may not be the answer.
    Clover AJ; McCarthy MJ
    Br J Plast Surg; 2003 Jan; 56(1):77. PubMed ID: 12706170
    [No Abstract]   [Full Text] [Related]  

  • 66. Circulating endothelial cells after transplantation.
    Gunsilius E; Petzer AL; Duba HC; Kahler CM; Gastl G
    Lancet; 2001 May; 357(9266):1449-50. PubMed ID: 11360955
    [No Abstract]   [Full Text] [Related]  

  • 67. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?
    Voelkel NF; Tuder RM
    J Clin Invest; 2000 Sep; 106(6):733-8. PubMed ID: 10995781
    [No Abstract]   [Full Text] [Related]  

  • 68. Therapeutic angiogenesis: time for the next phase.
    Pantely GA; Porter JM
    J Am Coll Cardiol; 2000 Oct; 36(4):1245-7. PubMed ID: 11028478
    [No Abstract]   [Full Text] [Related]  

  • 69. Walking the walk: migration and other common themes in blood and vascular development.
    Traver D; Zon LI
    Cell; 2002 Mar; 108(6):731-4. PubMed ID: 11955426
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Indian medical agencies probe illegal VEGF trials.
    Sharma DC
    Lancet; 2001 May; 357(9266):1422. PubMed ID: 11356453
    [No Abstract]   [Full Text] [Related]  

  • 71. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies.
    Aiello LP
    Ophthalmic Res; 1997; 29(5):354-62. PubMed ID: 9323726
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic angiogenesis.
    Henry TD
    BMJ; 1999 Jun; 318(7197):1536-9. PubMed ID: 10356013
    [No Abstract]   [Full Text] [Related]  

  • 73. Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues.
    Williams B
    Diabetologia; 1997 Jul; 40 Suppl 2():S118-20. PubMed ID: 9248715
    [No Abstract]   [Full Text] [Related]  

  • 74. Influence of host microvascular environment on tumour vascular endothelium.
    Kubitza M; Hickey L; Roberts WG
    Int J Exp Pathol; 1999 Feb; 80(1):1-10. PubMed ID: 10365081
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Angiogenesis as a biologic and prognostic indicator in human breast carcinoma.
    Engels K; Fox SB; Harris AL
    EXS; 1997; 79():113-56. PubMed ID: 9002231
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II.
    Idris I; Tyreman N; Gray S; Donnelly R
    Diabetologia; 2002 Feb; 45(2):291-2. PubMed ID: 11942316
    [No Abstract]   [Full Text] [Related]  

  • 77. Therapeutic angiogenesis: just the basic fact(or)s, please.
    Hirsch DD; Pantely GA
    J Am Coll Cardiol; 1997 Apr; 29(5):1107-8. PubMed ID: 9120167
    [No Abstract]   [Full Text] [Related]  

  • 78. Molecular mechanisms of blood vessel formation.
    Bussolino F; Mantovani A; Persico G
    Trends Biochem Sci; 1997 Jul; 22(7):251-6. PubMed ID: 9255066
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New options for untreatable coronary artery disease: angiogenesis and laser revascularization.
    Mukherjee D; Ellis SG
    Cleve Clin J Med; 2000 Aug; 67(8):577-83. PubMed ID: 10946453
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Advances in the molecular understanding of growth factor action underlying diabetic retinopathy].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 2000 Oct; 104(10):697-8. PubMed ID: 11081303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.